Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology

ORCID: 0000-0002-9451-6037

Publication year:
All
51 - 100 out of 273Page size: 50
Sort by: 1st author
  1. Published

    Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera

    Riley, C. H., Brimnes, M. K., Hansen, M., Jensen, M. K., Hasselbalch, Hans Carl, Kjaer, L., Straten, P. T. & Svane, Inge Marie, 2016, In: European Journal of Haematology. 97, 1, p. 83-92 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Increase in circulating CD4CD25Foxp3 T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α

    Riley, C. H., Morten Krogh, J., Brimnes, M. K., Straten, P. T., Svane, Inge Marie, Hasselbalch, Hans Carl & Bjerrum, O. W., 25 Aug 2011, In: Blood. 118, 8, p. 2170-2173 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Lynch syndrome-associated epithelial ovarian cancer and its immunological profile

    Rasmussen, M., Lim, K., Rambech, E., Andersen, Mads Hald, Svane, Inge Marie, Andersen, Ove, Jensen, L. H., Nilbert, Mef Christina & Therkildsen, C., 2021, In: Gynecologic Oncology. 162, 3, p. 686-693

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro

    Presti, M., Westergaard, M. C. W., Draghi, A., Chamberlain, C. A., Gokuldass, A., Svane, Inge Marie & dqp123, dqp123, 2021, In: Cancer Immunology, Immunotherapy. 70, p. 1771–1776

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Checkpoint inhibitors in breast cancer - current status

    Polk, A., Svane, Inge Marie, Andersson, M. & Nielsen, Dorte Lisbet, 2018, In: Cancer Treatment Reviews. 63, p. 122-134

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    MERTK Acts as a costimulatory receptor on human cd8 t cells

    Peeters, M. J. W., Dulkeviciute, D., Draghi, A., Ritter, C., Rahbech, A., Skadborg, S. K., Seremet, T., Simoes, A. M. C., Martinenaite, E., Halldorsdottir, H. R., Andersen, Mads Hald, Olofsson, G. H., Svane, Inge Marie, Rasmussen, Lene Juel, Met, Özcan, Becker, J. C., dqp123, dqp123, Desler, Claus & Straten, P. T., 2019, In: Cancer Immunology Research. 7, 9, p. 1472-1484 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting

    Pedersen, S., Larsen, K. O., Christensen, Alex Hørby, Svane, Inge Marie, Zerahn, B. & Ellebaek, E., 2022, In: Acta Oncologica. 61, 1, p. 45-51

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy

    Pedersen, S., Holmstroem, R. B., von Heymann, A., Tolstrup, L. K., Madsen, K., Petersen, M. A., Haslund, C. A., Ruhlmann, C. H., Schmidt, H., Johansen, Christoffer, Svane, Inge Marie & Ellebaek, E., 2023, In: Acta Oncologica. 62, 1, p. 62-69 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Real-world data on melanoma brain metastases and survival outcome

    Pedersen, S., Møller, Søren, dqp123, dqp123, Persson, Gitte F., Svane, Inge Marie & Ellebaek, E., 2022, In: Melanoma Research. 32, 3, p. 173-182 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study

    Pedersen, M., Westergaard, M. C. W., Milne, K., Nielsen, M., Borch, T. H., Poulsen, L. G., Hendel, Helle Westergren, Kennedy, M., Briggs, G., Ledoux, S., Nøttrup, T. J., Andersen, P., Hasselager, T., Met, Ö., Nelson, B. H., dqp123, dqp123 & Svane, Inge Marie, 2018, In: OncoImmunology. 7, 12, 12 p., e1502905.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Successful treatment with Ipilimumab and Interleukin‑2 in two patients with metastatic melanoma and systemic autoimmune disease

    Pedersen, M., Andersen, R., Larsen, P. N., Jacobsen, Søren, Thielsen, P., Thor Straten, P. & Svane, Inge Marie, Dec 2014, In: Cancer immunology, immunotherapy : CII. 63, 12, p. 1341-6 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Wildtype p53-specific Antibody and T-Cell Responses in Cancer Patients

    Pedersen, Anders Elm, Stryhn, A., Justesen, S., Harndahl, M., Rasmussen, S., Donskov, F., Claesson, Mogens Helweg, Pedersen, J. W., Wandall, Hans H., Svane, Inge Marie & Buus, Søren, 2011, In: Journal of Immunotherapy. 34, 9, p. 629-40 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Laser immunotherapy: A potential treatment modality for keratinocyte carcinoma

    Omland, S. H., Wenande, E. C., Svane, Inge Marie, Tam, J., Olesen, U. H. & Hædersdal, Merete, 2021, In: Cancers. 13, 21, 18 p., 5405.

    Research output: Contribution to journal › Review › Research › peer-review

  14. Published

    Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional Laser

    Omland, S. H., Ejlertsen, J. S., Krustrup, D., Christensen, R. L., Svane, Inge Marie, Olesen, U. H. & Hædersdal, Merete, 2022, In: Cancers. 14, 23, 5815.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    In-chip fabrication of free-form 3D constructs for directed cell migration analysis

    Olsen, M. H., Hjortø, Gertrud Malene, Hansen, M., Met, Özcan, Svane, Inge Marie & Larsen, N. B., 21 Dec 2013, In: Lab On a Chip. 13, 24, p. 4800-4809 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma

    Nitschke, N. J., Bjoern, J., Iversen, T. Z., Andersen, Mads Hald & Svane, Inge Marie, 2017, In: Stem Cell Investigation. 4, 13 p., 77.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Therapeutic Vaccination against A Modified Minimal Survivin Epitope Induces Functional CD4 T Cells That Recognize Survivin-Expressing Cells

    Nitschke, N. J., Bjoern, J., Met, Özcan, Svane, Inge Marie & Andersen, M. H., 1 Sep 2016, In: Scandinavian Journal of Immunology. 84, 3, p. 191-193 3 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  18. Published

    In vitro 4-1BB stimulation promotes expansion of CD8+ tumor-infiltrating lymphocytes from various sarcoma subtypes

    Nielsen, M., Krarup-Hansen, Anders, Hovgaard, D., Petersen, Michael Mørk, Loya, Anand Chainsukh, Westergaard, M. C. W., Svane, Inge Marie & Junker, N., 2020, In: Cancer Immunology, Immunotherapy. 69, p. 2179-2191

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Coexisting Alterations of MHC Class I Antigen Presentation and IFNg Signaling Mediate Acquired Resistance of Melanoma to Post-PD-1 Immunotherapy

    Nielsen, M., Presti, M., Sztupinszki, Z., Jensen, Agnete Witness Præst, Draghi, A., Chamberlain, C. A., Schina, A., Yde, C. W., Wojcik, J., Szallasi, Z., Crowther, M. D., Svane, Inge Marie & Donia, M., 2022, In: Cancer Immunology Research. 10, 10, p. 1254-1262 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    Chimeric antigen receptor-T-cellebehandling

    Muller, Klaus, Ifversen, M., Kielsen, K., Petersen, S. L., Met, Ö. & Svane, Inge Marie, 2019, In: Ugeskrift for Laeger. 181, 20A, 5 p., V05190309.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer

    Mørk, S. K., Kongsted, P., Westergaard, M. C. W., Albieri, B., Granhøj, J. S., Donia, M., Martinenaite, E., Holmström, M. O., Madsen, K., Kverneland, A. H., Kjeldsen, J. W., Holmstroem, R. B., Lorentzen, C. L., Nørgaard, N., Andreasen, L. V., Wood, G. K., Christensen, D., Klausen, M. S., Hadrup, S. R., thor Straten, P. & 2 others, Andersen, Mads Hald & Svane, Inge Marie, 2023, In: Frontiers in Immunology. 14, 1122977.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Real-time monitoring of mitochondrial respiration in cytokine-differentiated human primary T cells

    Mølgaard, K., Rahbech, Anne, Met, Özcan, Svane, Inge Marie, Straten, P., Desler, Claus & Peeters, M. J. W., 2021, In: Journal of Visualized Experiments. 176, e62984.

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    Reduced mitochondrial respiration in peripheral T cells after paediatric heamatopoietic stem cell transplantation

    Mølgaard, K., Kielsen, K., Ifversen, M., Met, Özcan, Svane, Inge Marie & Muller, Klaus, 2024, In: Frontiers in Immunology. 14, 1327977.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine

    Munir Ahmad, S., Martinenaite, E., Hansen, M., Junker, N., Borch, T. H., Met, Özcan, Donia, M., Svane, Inge Marie & Andersen, Mads Hald, 2 Aug 2016, In: OncoImmunology. 5, 8, e1202391.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase

    Munir, S., Larsen, S. K., Iversen, T. Z., Donia, M., Klausen, T. W., Svane, Inge Marie, Straten, P. T. & Andersen, M. H., 2012, In: P L o S One. 7, 4, p. e34568

    Research output: Contribution to journal › Journal article › Research › peer-review

  26. Published

    Characterization of T-cell responses against IκBα in cancer patients

    Munir, S., Frøsig, T. M., Hansen, M., Svane, Inge Marie & Andersen, M. H., 2012, In: OncoImmunology. 1, 8, p. 1290-1296 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  27. Published

    The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells

    Munir, S., Andersen, G. H., Svane, Inge Marie & Andersen, Mads Hald, 2013, In: OncoImmunology. 2, 4, 9 p., e23991.

    Research output: Contribution to journal › Journal article › Research › peer-review

  28. Published

    HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients

    Munir, S., Andersen, G. H., Met, Özcan, Donia, M., Frøsig, T. M., Larsen, S. K., Klausen, T. W., Svane, Inge Marie & Andersen, Mads Hald, 15 Mar 2013, In: Cancer Research. 73, 6, p. 1764-76 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  29. Published

    Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

    Mortensen, R. E. J., Holmström, M. O., Lisle, T. L., Hasselby, Jane Preuss, Willemoe, G. L., Met, Özcan, Svane, Inge Marie, Johansen, Julia Sidenius, Nielsen, Dorte Lisbet, Chen, I. M. & Andersen, Mads Hald, 2023, In: Journal for ImmunoTherapy of Cancer. 11, 3

    Research output: Contribution to journal › Journal article › Research › peer-review

  30. Published

    Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma

    Mork, S. K., Kadivar, M., Bol, K. F., Draghi, A., Westergaard, M. C. W., Skadborg, S. K., Overgaard, N., Sorensen, A. B., Rasmussen, I. S., Andreasen, L. V., Yde, C. W., Trolle, T., Garde, C., Friis-Nielsen, J., Norgaard, N., Christensen, D., Kringelum, J. V., dqp123, dqp123, Hadrup, S. R. & Svane, Inge Marie, 31 Dec 2022, In: OncoImmunology. 11, 1, 15 p., 2023255.

    Research output: Contribution to journal › Journal article › Research › peer-review

  31. Published

    ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors

    Morgan Hulen , T., Chamberlain, C. A., Svane, Inge Marie & Met, Özcan, 2021, In: Immuno. 1, 3, p. 194-211

    Research output: Contribution to journal › Journal article › Research › peer-review

  32. Published

    TIL Therapy: Facts and Hopes

    Monberg, Tine Juul, Borch, T. H., Svane, Inge Marie & Donia, M., 2023, In: Clinical Cancer Research. 29, 17, p. 3275-3283 9 p.

    Research output: Contribution to journal › Review › Research › peer-review

  33. Published

    High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer

    Met, Özcan, Balslev, E., Flyger, H. & Svane, Inge Marie, 1 Jan 2011, In: Breast Cancer Research and Treatment. 125, 2, p. 395-406 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  34. Published

    Principles of adoptive T cell therapy in cancer

    Met, Özcan, Jensen, K. M., Chamberlain, C. A., dqp123, dqp123 & Svane, Inge Marie, 11 Jan 2019, In: Seminars in Immunopathology. 41, 1, p. 49–58

    Research output: Contribution to journal › Journal article › Research › peer-review

  35. Published

    Analysis of Survivin-Specific T Cells in Breast Cancer Patients Using Human DCs Engineered with Survivin mRNA

    Met, Özcan & Svane, Inge Marie, 2013, Synthetic Messenger RNA and Cell Metabolism Modulation. Vol. 969. p. 275-292 18 p. (Methods in Molecular Biology).

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

  36. Published

    Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potential

    Met, Özcan, Eriksen, J. & Svane, Inge Marie, Oct 2008, In: Molecular Biotechnology. 40, 2, p. 151-60 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  37. Published

    Studies on mRNA electroporation of immature and mature dendritic cells: Effects on their immunogenic potential

    Met, O., Eriksen, J. & Svane, Inge Marie, 2008, In: Journal of Molecular Microbiology and Biotechnology. 40, 2, p. 151-160 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  38. Published

    Frequent adaptive immune responses against arginase-1

    Martinenaite, E., Mortensen, R. E. J., Hansen, M., Orebo Holmström, M., Munir Ahmad, S., Grønne Dahlager Jørgensen, N., Met, Özcan, dqp123, dqp123, Svane, Inge Marie & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 3, 9 p., e1404215.

    Research output: Contribution to journal › Journal article › Research › peer-review

  39. Published

    Peripheral memory T cells specific for Arginase-1

    Martinenaite, E., Ahmad, S. M., Svane, Inge Marie & Andersen, Mads Hald, 2019, In: Cellular and Molecular Immunology. 16, 8, p. 718-719 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  40. Published

    CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment

    Martinenaite, E., Munir Ahmad, S., Hansen, M., Met, Özcan, Westergaard, M. W., Larsen, S. K., Klausen, T. W., Donia, M., Svane, Inge Marie & Andersen, Mads Hald, 2016, In: OncoImmunology. 5, 11, 10 p., e1238541.

    Research output: Contribution to journal › Journal article › Research › peer-review

  41. Published

    Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope

    Martinenaite, E., Ahmad, S. M., Bendtsen, S. K., Jørgensen, M. A., Weis-Banke, S. E., Svane, Inge Marie & Andersen, Mads Hald, 2019, In: Cancer Immunology, Immunotherapy. 68, 11, p. 1901-1907 7 p.

    Research output: Contribution to journal › Review › Research › peer-review

  42. Published

    Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial

    Lorentzen, C. L., Martinenaite, E., Kjeldsen, J. W., Holmstroem, R. B., Mørk, S. K., Pedersen, A. W., Ehrnrooth, E., Andersen, Mads Hald & Svane, Inge Marie, 2022, In: Frontiers in Immunology. 13, 1023023.

    Research output: Contribution to journal › Journal article › Research › peer-review

  43. Published

    Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab

    Lorentzen, C. L., Kjeldsen, J. W., Ehrnrooth, E., Andersen, M. H. & Svane, Inge Marie, 2023, In: Journal for ImmunoTherapy of Cancer. 11, 5, 10 p., e006755.

    Research output: Contribution to journal › Journal article › Research › peer-review

  44. Published

    Clinical advances and ongoing trials on mRNA vaccines for cancer treatment

    Lorentzen, C. L., Haanen, J. B., Met, Özcan & Svane, Inge Marie, 2022, In: The Lancet Oncology. 23, 10, p. e450-e458

    Research output: Contribution to journal › Review › Research › peer-review

  45. Published

    Escape from nonsense-mediated decay associates with anti-tumor immunogenicity

    Litchfield, K., Reading, J. L., Lim, E. L., Xu, H., Liu, P., Al-bakir, M., Wong, Y. N. S., Rowan, A., Funt, S. A., Merghoub, T., Perkins, D., Lauss, M., Svane, Inge Marie, Jönsson, G., Herrero, J., Larkin, J., Quezada, S. A., Hellmann, M. D., Turajlic, S. & Swanton, C., 1 Dec 2020, In: Nature Communications. 11, 1, 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  46. Published

    Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

    Lebbé, C., Meyer, N., Mortier, L., Marquez-Rodas, I., Robert, C., Rutkowski, P., Menzies, A. M., Eigentler, T., Ascierto, P. A., Smylie, M., Schadendorf, D., Ajaz, M., Svane, Inge Marie, Gonzalez, R., Rollin, L., Lord-Bessen, J., Saci, A., Grigoryeva, E. & Pigozzo, J., 2019, In: Journal of Clinical Oncology. 37, 11, p. 867-875

    Research output: Contribution to journal › Journal article › Research › peer-review

  47. Published

    Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

    Lauss, M., dqp123, dqp123, Harbst, K., Andersen, R., Mitra, S., Rosengren, F., Salim, M., Vallon-Christersson, J., Törngren, T., Kvist, A., Ringnér, M., Svane, Inge Marie & Jönsson, G., 2017, In: Nature Communications. 8, 11 p., 1738.

    Research output: Contribution to journal › Journal article › Research › peer-review

  48. Published

    B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?

    Lauss, M., dqp123, dqp123, Svane, Inge Marie & Jönsson, G., 2022, In: Clinical Cancer Research. 28, 9, p. 1751–1758 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  49. Published

    Therapeutic cancer vaccines

    Larsen, S. K., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 2010, In: Current Cancer Therapy Reviews. 6, 2, p. 163-174

    Research output: Contribution to journal › Journal article › Research › peer-review

  50. Published

    Spontaneous presence of FOXO3-specific T cells in cancer patients

    Larsen, S. K., Ahmad, S. M., Idorn, M., Met, Özcan, Martinenaite, E., Svane, Inge Marie, Straten, P. T. & Andersen, Mads Hald, 1 Jan 2014, In: OncoImmunology. 3, 8, e953411.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 Next

ID: 4054758